In line with these observations, an increased number of IL-22-producing cells infiltrating the tumor and high levels of IL-22 in the serum of patients were found to be negative prognostic factors for the progression of HCC [43,44,45]. The gene discussed is IL22; the disease is hepatocellular carcinoma.